| MeSH term | MeSH ID | Detail |
|---|---|---|
| Dysbiosis | D064806 | 2 associated lipids |
| Chronic Pain | D059350 | 5 associated lipids |
| Peripheral Nerve Injuries | D059348 | 6 associated lipids |
| Peripheral Arterial Disease | D058729 | 7 associated lipids |
| Plaque, Atherosclerotic | D058226 | 7 associated lipids |
| Plaque, Amyloid | D058225 | 19 associated lipids |
| Acute Kidney Injury | D058186 | 34 associated lipids |
| Geographic Atrophy | D057092 | 1 associated lipids |
| Acute Lung Injury | D055371 | 33 associated lipids |
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | D054218 | 5 associated lipids |
DHA
Dha is a lipid of Fatty Acyls (FA) class. Dha is associated with abnormalities such as Atherosclerosis, Consumption-archaic term for TB, Chronic disease, Cardiovascular Diseases and Diabetes Mellitus, Non-Insulin-Dependent. The involved functions are known as Inflammation, Oxidation, fatty acid oxidation, Fatty Acid Metabolism and Lipid Metabolism. Dha often locates in Hepatic, Protoplasm, Mucous Membrane, Epithelium and outer membrane. The associated genes with DHA are IMPACT gene, FATE1 gene, GAPDH gene, THOC4 gene and SLC33A1 gene. The related lipids are stearidonic acid, Fatty Acids, Total cholesterol, Lipopolysaccharides and Dietary Fatty Acid. The related experimental models are Mouse Model, Transgenic Model, Animal Disease Models and Arthritis, Experimental.
Cross Reference
Introduction
To understand associated biological information of DHA, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with DHA?
DHA is suspected in Cardiovascular Diseases, Obesity, Ischemia, Hypertensive disease, Coronary Arteriosclerosis, Cerebrovascular accident and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with DHA
PubChem Associated disorders and diseases
What pathways are associated with DHA
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with DHA?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with DHA?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with DHA?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with DHA?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with DHA?
Mouse Model
Mouse Model are used in the study 'Homeostatic regulation of photoreceptor cell integrity: significance of the potent mediator neuroprotectin D1 biosynthesized from docosahexaenoic acid: the Proctor Lecture.' (Bazan NG, 2007), Mouse Model are used in the study 'Omega-3 fatty acids EPA and DHA: health benefits throughout life.' (Swanson D et al., 2012), Mouse Model are used in the study 'Docosahexaenoic acid attenuates hepatic inflammation, oxidative stress, and fibrosis without decreasing hepatosteatosis in a Ldlr(-/-) mouse model of western diet-induced nonalcoholic steatohepatitis.' (Depner CM et al., 2013) and Mouse Model are used in the study 'Wax esters from the marine copepod Calanus finmarchicus reduce diet-induced obesity and obesity-related metabolic disorders in mice.' (Höper AC et al., 2014).
Transgenic Model
Transgenic Model are used in the study 'Loss of MAP function leads to hippocampal synapse loss and deficits in the Morris Water Maze with aging.' (Ma QL et al., 2014).
Animal Disease Models
Animal Disease Models are used in the study 'Fish oil increases muscle protein mass and modulates Akt/FOXO, TLR4, and NOD signaling in weanling piglets after lipopolysaccharide challenge.' (Liu Y et al., 2013).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with DHA
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Jones CR et al. | Evidence for the involvement of docosahexaenoic acid in cholinergic stimulated signal transduction at the synapse. | 1997 | Neurochem. Res. | pmid:9178948 |
| Ikemoto A et al. | Membrane fatty acid modifications of PC12 cells by arachidonate or docosahexaenoate affect neurite outgrowth but not norepinephrine release. | 1997 | Neurochem. Res. | pmid:9178949 |
| Lee HJ et al. | Topiramate does not alter the kinetics of arachidonic or docosahexaenoic acid in brain phospholipids of the unanesthetized rat. | 2005 | Neurochem. Res. | pmid:16176072 |
| Prasad MR et al. | Regional membrane phospholipid alterations in Alzheimer's disease. | 1998 | Neurochem. Res. | pmid:9482271 |
| Chang MC et al. | Dynamics of docosahexaenoic acid metabolism in the central nervous system: lack of effect of chronic lithium treatment. | 1999 | Neurochem. Res. | pmid:10215514 |
| Brown J et al. | Binge ethanol-induced neurodegeneration in rat organotypic brain slice cultures: effects of PLA2 inhibitor mepacrine and docosahexaenoic acid (DHA). | 2009 | Neurochem. Res. | pmid:18592376 |
| Terrian DM et al. | Glutamate is the endogenous amino acid selectively released by rat hippocampal mossy fiber synaptosomes concomitantly with prodynorphin-derived peptides. | 1990 | Neurochem. Res. | pmid:1970130 |
| Dagai L et al. | Docosahexaenoic acid significantly stimulates immediate early response genes and neurite outgrowth. | 2009 | Neurochem. Res. | pmid:18781386 |
| Fraser T et al. | Fatty acid composition of frontal, temporal and parietal neocortex in the normal human brain and in Alzheimer's disease. | 2010 | Neurochem. Res. | pmid:19904605 |
| Giesing M and Zilliken F | Lipid metabolism of developing central nervous tissues in organotypic cultures. III. Ganglionic control of glycerolipids and fatty acids in cortex grey matter. | 1980 | Neurochem. Res. | pmid:6445512 |
| Schonfeld E et al. | Docosahexaenoic acid enhances iron uptake by modulating iron transporters and accelerates apoptotic death in PC12 cells. | 2007 | Neurochem. Res. | pmid:17551831 |
| Narita K et al. | Therapeutic time window in the penumbra during permanent focal ischemia in rats: changes of free fatty acids and glycerophospholipids. | 2000 | Neurol. Res. | pmid:10874689 |
| Ajami M et al. | Expression of Bcl-2 and Bax after hippocampal ischemia in DHA + EPA treated rats. | 2011 | Neurol. Sci. | pmid:21617951 |
| Ammann EM et al. | ω-3 fatty acids and domain-specific cognitive aging: secondary analyses of data from WHISCA. | 2013 | Neurology | pmid:24068783 |
| Martinez M and Vazquez E | MRI evidence that docosahexaenoic acid ethyl ester improves myelination in generalized peroxisomal disorders. | 1998 | Neurology | pmid:9674774 |
| MartÃnez M | Severe deficiency of docosahexaenoic acid in peroxisomal disorders: a defect of delta 4 desaturation? | 1990 | Neurology | pmid:2143272 |
| Pottala JV et al. | Higher RBC EPA + DHA corresponds with larger total brain and hippocampal volumes: WHIMS-MRI study. | 2014 | Neurology | pmid:24453077 |
| Paker AM et al. | Docosahexaenoic acid therapy in peroxisomal diseases: results of a double-blind, randomized trial. | 2010 | Neurology | pmid:20805528 |
| Martinez M et al. | Docosahexaenoic acid--a new therapeutic approach to peroxisomal-disorder patients: experience with two cases. | 1993 | Neurology | pmid:8327143 |
| Dyall SC and Michael-Titus AT | Neurological benefits of omega-3 fatty acids. | 2008 | Neuromolecular Med. | pmid:18543124 |
| Zhao Z and Zlokovic BV | Blood-brain barrier: a dual life of MFSD2A? | 2014 | Neuron | pmid:24853933 |
| Mucke L and Pitas RE | Food for thought: essential fatty acid protects against neuronal deficits in transgenic mouse model of AD. | 2004 | Neuron | pmid:15339638 |
| Calon F et al. | Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model. | 2004 | Neuron | pmid:15339646 |
| Suganuma H et al. | Maternal docosahexaenoic acid-enriched diet prevents neonatal brain injury. | 2010 | Neuropathology | pmid:20408962 |
| Tamim MK et al. | Effect of non-dopaminergic drug treatment on Levodopa induced dyskinesias in MPTP monkeys: common implication of striatal neuropeptides. | 2010 | Neuropharmacology | pmid:19576910 |
| Poling JS et al. | Docosahexaenoic acid block of neuronal voltage-gated K+ channels: subunit selective antagonism by zinc. | 1996 | Neuropharmacology | pmid:8938727 |
| Bate C et al. | Docosahexaenoic and eicosapentaenoic acids increase neuronal death in response to HuPrP82-146 and Abeta 1-42. | 2008 | Neuropharmacology | pmid:18355880 |
| Li Z et al. | Dehydroepiandrosterone sulfate prevents ischemia-induced impairment of long-term potentiation in rat hippocampal CA1 by up-regulating tyrosine phosphorylation of NMDA receptor. | 2006 | Neuropharmacology | pmid:16895729 |
| Molloy C et al. | Docosahexaenoic acid and visual functioning in preterm infants: a review. | 2012 | Neuropsychol Rev | pmid:23065239 |
| Baldessarini RJ et al. | Fatty acid derivatives of clozapine: prolonged antidopaminergic activity of docosahexaenoylclozapine in the rat. | 2001 | Neuropsychopharmacology | pmid:11106876 |
| Ethier I et al. | The transcription factor NGFI-B (Nur77) and retinoids play a critical role in acute neuroleptic-induced extrapyramidal effect and striatal neuropeptide gene expression. | 2004 | Neuropsychopharmacology | pmid:14603264 |
| Lu DY et al. | Docosahexaenoic acid suppresses neuroinflammatory responses and induces heme oxygenase-1 expression in BV-2 microglia: implications of antidepressant effects for ω-3 fatty acids. | 2010 | Neuropsychopharmacology | pmid:20668435 |
| Wu A et al. | Dietary strategy to repair plasma membrane after brain trauma: implications for plasticity and cognition. | 2014 | Neurorehabil Neural Repair | pmid:23911971 |
| Wang X et al. | Neuroprotective effect of docosahexaenoic acid on glutamate-induced cytotoxicity in rat hippocampal cultures. | 2003 | Neuroreport | pmid:14663210 |
| Reynolds LM et al. | Phospholipid fatty acids and neurotoxicity in human neuroblastoma SH-SY5Y cells. | 2001 | Neurosci. Lett. | pmid:11514074 |
| Pilitsis JG et al. | Free fatty acids in cerebrospinal fluids from patients with traumatic brain injury. | 2003 | Neurosci. Lett. | pmid:12946571 |
| Hossain MS et al. | Influence of docosahexaenoic acid on cerebral lipid peroxide level in aged rats with and without hypercholesterolemia. | 1998 | Neurosci. Lett. | pmid:9593513 |
| Petroni A et al. | The beta-oxidation of arachidonic acid and the synthesis of docosahexaenoic acid are selectively and consistently altered in skin fibroblasts from three Zellweger patients versus X-adrenoleukodystrophy, Alzheimer and control subjects. | 1998 | Neurosci. Lett. | pmid:9708853 |
| Milne GL et al. | Elevated oxidation of docosahexaenoic acid, 22:6 (n-3), in brain regions of rats undergoing ethanol withdrawal. | 2006 | Neurosci. Lett. | pmid:16875780 |
| Yamane M and Abe A | Properties of the omega-hydroxylation system of docosahexaenoic or arachidonic acid in brain or liver homogenate of rat. | 1995 | Neurosci. Lett. | pmid:9064612 |
| Reddy TS et al. | Change in content, incorporation and lipoxygenation of docosahexaenoic acid in retina and retinal pigment epithelium in canine ceroid lipofuscinosis. | 1985 | Neurosci. Lett. | pmid:2931631 |
| Bourre JM and Dumont O | The administration of pig brain phospholipids versus soybean phospholipids in the diet during the period of brain development in the rat results in greater increments of brain docosahexaenoic acid. | 2002 | Neurosci. Lett. | pmid:12459515 |
| Gazzah N et al. | Evidence for brain docosahexaenoate recycling in the free-moving adult rat: implications for measurement of phospholipid synthesis. | 1994 | Neurosci. Lett. | pmid:7824158 |
| Sarda N et al. | Docosahexaenoic acid (cervonic acid) incorporation into different brain regions in the awake rat. | 1991 | Neurosci. Lett. | pmid:1829511 |
| Young C et al. | Cancellation of low-frequency stimulation-induced long-term depression by docosahexaenoic acid in the rat hippocampus. | 1998 | Neurosci. Lett. | pmid:9655627 |
| Vaidyanathan VV et al. | Regulation of diacylglycerol kinase in rat brain membranes by docosahexaenoic acid. | 1994 | Neurosci. Lett. | pmid:7845615 |
| Alberghina M et al. | Differential transport of docosahexaenoate and palmitate through the blood-retina and blood-brain barrier of the rat. | 1994 | Neurosci. Lett. | pmid:8084474 |
| Fonlupt P et al. | Incorporation of arachidonic and docosahexaenoic acids into phospholipids of rat brain membranes. | 1994 | Neurosci. Lett. | pmid:8084475 |
| Kotani S et al. | Dietary supplementation of arachidonic and docosahexaenoic acids improves cognitive dysfunction. | 2006 | Neurosci. Res. | pmid:16905216 |
| Cansev M et al. | Restorative effects of uridine plus docosahexaenoic acid in a rat model of Parkinson's disease. | 2008 | Neurosci. Res. | pmid:18761383 |
| Gomez-Pinilla F and Ying Z | Differential effects of exercise and dietary docosahexaenoic acid on molecular systems associated with control of allostasis in the hypothalamus and hippocampus. | 2010 | Neuroscience | pmid:20303394 |
| McGahon BM et al. | Age-related changes in synaptic function: analysis of the effect of dietary supplementation with omega-3 fatty acids. | 1999 | Neuroscience | pmid:10613520 |
| Katakura M et al. | Docosahexaenoic acid promotes neuronal differentiation by regulating basic helix-loop-helix transcription factors and cell cycle in neural stem cells. | 2009 | Neuroscience | pmid:19272428 |
| Cansev M and Wurtman RJ | Chronic administration of docosahexaenoic acid or eicosapentaenoic acid, but not arachidonic acid, alone or in combination with uridine, increases brain phosphatide and synaptic protein levels in gerbils. | 2007 | Neuroscience | pmid:17683870 |
| Okada M et al. | The chronic administration of docosahexaenoic acid reduces the spatial cognitive deficit following transient forebrain ischemia in rats. | 1996 | Neuroscience | pmid:8834389 |
| Högyes E et al. | Neuroprotective effect of developmental docosahexaenoic acid supplement against excitotoxic brain damage in infant rats. | 2003 | Neuroscience | pmid:12831859 |
| Strokin M et al. | Neuroprotection of rat hippocampal slices exposed to oxygen-glucose deprivation by enrichment with docosahexaenoic acid and by inhibition of hydrolysis of docosahexaenoic acid-containing phospholipids by calcium independent phospholipase A2. | 2006 | Neuroscience | pmid:16563639 |
| Koumura A et al. | A novel calpain inhibitor, ((1S)-1((((1S)-1-benzyl-3-cyclopropylamino-2,3-di-oxopropyl)amino)carbonyl)-3-methylbutyl) carbamic acid 5-methoxy-3-oxapentyl ester, protects neuronal cells from cerebral ischemia-induced damage in mice. | 2008 | Neuroscience | pmid:18835333 |
| Lu Y et al. | Spinal injection of docosahexaenoic acid attenuates carrageenan-induced inflammatory pain through inhibition of microglia-mediated neuroinflammation in the spinal cord. | 2013 | Neuroscience | pmid:23500096 |
| Wu A et al. | Exercise facilitates the action of dietary DHA on functional recovery after brain trauma. | 2013 | Neuroscience | pmid:23811071 |
| Horimoto N et al. | Arachidonic acid activation of potassium channels in rat visual cortex neurons. | 1997 | Neuroscience | pmid:9070743 |
| Wu A et al. | Docosahexaenoic acid dietary supplementation enhances the effects of exercise on synaptic plasticity and cognition. | 2008 | Neuroscience | pmid:18620024 |
| Arnal E et al. | Lutein and docosahexaenoic acid prevent cortex lipid peroxidation in streptozotocin-induced diabetic rat cerebral cortex. | 2010 | Neuroscience | pmid:20036322 |
| Kawakita E et al. | Docosahexaenoic acid promotes neurogenesis in vitro and in vivo. | 2006 | Neuroscience | pmid:16527422 |
| Gamoh S et al. | Chronic administration of docosahexaenoic acid improves reference memory-related learning ability in young rats. | 1999 | Neuroscience | pmid:10430487 |
| Phivilay A et al. | High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer's disease. | 2009 | Neuroscience | pmid:19135506 |
| Dhobale M et al. | Association of brain-derived neurotrophic factor and tyrosine kinase B receptor in pregnancy. | 2012 | Neuroscience | pmid:22542551 |
| Su KP | Biological mechanism of antidepressant effect of omega-3 fatty acids: how does fish oil act as a 'mind-body interface'? | 2009 | Neurosignals | pmid:19190401 |
| Kindler DD et al. | Update on therapies for acute ischemic stroke. | 2000 | Neurosurg Focus | pmid:16859280 |
| Mills JD et al. | Dietary supplementation with the omega-3 fatty acid docosahexaenoic acid in traumatic brain injury. | 2011 | Neurosurgery | pmid:21135750 |
| Bate C et al. | Polyunsaturated fatty acids protect against prion-mediated synapse damage in vitro. | 2010 | Neurotox Res | pmid:19644728 |
| Collins MA et al. | Docosahexaenoic acid (DHA) prevents binge ethanol-dependent aquaporin-4 elevations while inhibiting neurodegeneration: experiments in rat adult-age entorhino-hippocampal slice cultures. | 2013 | Neurotox Res | pmid:23184649 |
| Ozsoy O et al. | The effect of docosahexaenoic Acid on visual evoked potentials in a mouse model of Parkinson's disease: the role of cyclooxygenase-2 and nuclear factor kappa-B. | 2011 | Neurotox Res | pmid:21234736 |
| Kimura S et al. | Docosahexaenoic acid attenuated hypertension and vascular dementia in stroke-prone spontaneously hypertensive rats. | 2002 Sep-Oct | Neurotoxicol Teratol | pmid:12200199 |
| Ji A et al. | n-3 polyunsaturated fatty acids inhibit lipopolysaccharide-induced microglial activation and dopaminergic injury in rats. | 2012 | Neurotoxicology | pmid:22406923 |
| Yang DY et al. | Detrimental effects of post-treatment with fatty acids on brain injury in ischemic rats. | 2007 | Neurotoxicology | pmid:17854901 |
| Kaur P et al. | Docosahexaenoic acid may act as a neuroprotector for methylmercury-induced neurotoxicity in primary neural cell cultures. | 2008 | Neurotoxicology | pmid:18619488 |
| Furuya H et al. | Effect of ethanol and docosahexaenoic acid on nerve growth factor-induced neurite formation and neuron specific growth-associated protein gene expression in PC12 cells. | 2002 | Nihon Arukoru Yakubutsu Igakkai Zasshi | pmid:12462067 |
| Kawabata T et al. | [Comparison of long-chain polyunsaturated fatty acids in plasma and erythrocyte phospholipids for biological monitoring]. | 2011 | Nihon Eiseigaku Zasshi | pmid:21358141 |
| Sasaki H et al. | [Immunosuppressive effect of intravenously injected docosahexaenoic acid on single lung allotransplantation in the rat]. | 1996 | Nihon Kyobu Geka Gakkai Zasshi | pmid:8741552 |
| Yui K et al. | [Therapeutic effects of larger doses of arachidonic acid added to DHA on social impairment and its relation to alterations of polyunsaturated fatty acids in individuals with autism spectrum disorders]. | 2011 | Nihon Shinkei Seishin Yakurigaku Zasshi | pmid:21800702 |
| Amamoto T et al. | [Relationship between hippocampal arachidonic acid content and induction of LTP in aged rats]. | 1999 | Nihon Shinkei Seishin Yakurigaku Zasshi | pmid:10803212 |
| Yoshizawa K and Tsubura A | [Characteristics of N-methyl-N-nitrosourea-induced retinal degeneration in animals and application for the therapy of human retinitis pigmentosa]. | 2005 | Nippon Ganka Gakkai Zasshi | pmid:16047940 |
| Shimakata T | [Polyunsaturated fatty acid]. | 2001 | Nippon Rinsho | pmid:11351628 |
| Orii T et al. | [Peroxisomal disorders--DNA analysis]. | 1993 | Nippon Rinsho | pmid:8096253 |
| Katsumata T and Katayama Y | [Icosapentanoic acid (EPA), docosahexanoic acid (DHA)]. | 2004 | Nippon Rinsho | pmid:15658280 |
| Hirafuji M et al. | [Specific modulation of vascular smooth muscle cell functions by docosahexaenoic acid]. | 1997 | Nippon Yakurigaku Zasshi | pmid:9503427 |
| Asai M et al. | [Cellular models for individualized medicine in Alzheimer's disease using patient-derived induced pluripotent stem cells]. | 2014 | Nippon Yakurigaku Zasshi | pmid:24420133 |
| Hashimoto M et al. | [Mechanism of improvement of spatial cognition with dietary docosahexaenoic acid]. | 2002 | Nippon Yakurigaku Zasshi | pmid:12491779 |
| Imamura T | [Ameliorative effect of n-3 fatty acid on insulin resistance through GPR120]. | 2010 | Nippon Yakurigaku Zasshi | pmid:21313786 |
| Hieda K et al. | Pharmacological effect of functional foods with a hypotensive action. | 2015 | Nippon Yakurigaku Zasshi | pmid:26165340 |
| Li P et al. | Dietary supplementation with cholesterol and docosahexaenoic acid increases the activity of the arginine-nitric oxide pathway in tissues of young pigs. | 2008 | Nitric Oxide | pmid:18555806 |
| Mabe H et al. | [Effect of calcium entry blocker, nimodipine, on the cerebral function and metabolic recovery following experimental cerebral ischemia]. | 1985 | No To Shinkei | pmid:2934079 |
| Hussar DA | New drugs 06, part II. | 2006 | Nursing | pmid:16888514 |
| Kikawa KD et al. | Induced oxidative stress and cell death in the A549 lung adenocarcinoma cell line by ionizing radiation is enhanced by supplementation with docosahexaenoic acid. | 2010 | Nutr Cancer | pmid:21058189 |
| Macášek J et al. | Plasma fatty acid composition in patients with pancreatic cancer: correlations to clinical parameters. | 2012 | Nutr Cancer | pmid:23061902 |
| Kato T et al. | Docosahexaenoic acid (DHA), a primary tumor suppressive omega-3 fatty acid, inhibits growth of colorectal cancer independent of p53 mutational status. | 2007 | Nutr Cancer | pmid:17640164 |
| Friedrichs W et al. | Omega-3 fatty acid inhibition of prostate cancer progression to hormone independence is associated with suppression of mTOR signaling and androgen receptor expression. | 2011 | Nutr Cancer | pmid:21667400 |
| Hardman WE and Ion G | Suppression of implanted MDA-MB 231 human breast cancer growth in nude mice by dietary walnut. | 2008 | Nutr Cancer | pmid:18791931 |
| Pascale AW et al. | Omega-3 fatty acid modification of membrane structure and function. II. Alteration by docosahexaenoic acid of tumor cell sensitivity to immune cytolysis. | 1993 | Nutr Cancer | pmid:8502585 |